Literature DB >> 31875907

Grossing Technology Today and Tomorrow.

Izak B Dimenstein1.   

Abstract

OBJECTIVE: To describe the perspective of grossing technology and highlight the prospective of its development in histology laboratory.
METHODS: Analysis of different components of grossing technology.
RESULTS: Increased requirements for a specimen's turnaround time and the advancements in modern processing equipment make the triage of workflow a significant part of a grossing person's responsibilities. The implementation of digital pathology in morphology studies practice requires standardization of fixation, the thickness of gross section, and optimal embedding orientation. To meet tomorrow's challenges, grossing technology should work on embedding automation and gross digital pathology to record gross sections corresponding the microscope slide. Specialization of grossing stations might be beneficial to the quality of processing and smooth workflow productivity. The emerging grossing technologist subspecialty requires development of a special training program.
CONCLUSION: Grossing technology can contribute to new challenges in modern histology laboratory, assuring high-quality microscope slides for the pathologist's diagnosis and research evaluation. © American Society for Clinical Pathology 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  digital pathology; embedding automation; grossing station; grossing technologist training; grossing technology; standardization gross section; workflow triage

Mesh:

Year:  2020        PMID: 31875907     DOI: 10.1093/labmed/lmz081

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  2 in total

1.  Value of an Action Cam in Surgical Pathology.

Authors:  Konstantin Bräutigam; Lucine Christe; Yara Banz
Journal:  Med Sci Educ       Date:  2021-11-29

2.  Hyperspectral and multispectral image processing for gross-level tumor detection in skin lesions: a systematic review.

Authors:  Eleni Aloupogianni; Masahiro Ishikawa; Naoki Kobayashi; Takashi Obi
Journal:  J Biomed Opt       Date:  2022-06       Impact factor: 3.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.